Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02302339
Title A Study of Glembatumumab Vedotin in Patients With Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celldex Therapeutics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Northern California Melanoma Center/St. Mary's Medical Center San Francisco California 94117 United States Details
Florida Cancer Specialists Fort Myers Florida 33916 United States Details
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140 United States Details
Florida Cancer Specialists West Palm Beach Florida 33407 United States Details
Northside Hospital Cancer Institute Atlanta Georgia 30341 United States Details
University of Chicago Medicine Chicago Illinois 60637 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
New York University School of Medicine New York New York 10016 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Baylor Research Institute-Sammons Cancer Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field